HeartSciences Secures $3.6 Million Unsecured Loan from Streeterville Capital

Reuters01-17
HeartSciences Secures $3.6 Million Unsecured Loan from Streeterville Capital

HeartSciences Inc. has entered into a new financing agreement with Streeterville Capital, LLC, an institutional investor. Under the Note Purchase Agreement signed on January 13, 2026, Streeterville purchased an unsecured promissory note from HeartSciences valued at $3,605,000. This amount includes an original issue discount of $600,000 and reimbursement of $5,000 in transaction expenses, resulting in gross proceeds of $3,000,000 to HeartSciences. The agreement contains customary covenants, representations, warranties, and events of default, including provisions that accelerate repayment if the company undergoes certain fundamental transactions without Streeterville's consent. The agreement also provides for indemnification of Streeterville in the event of breaches by HeartSciences.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-005245), on January 16, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment